Nature genetics 2016-04
Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.
ABSTRACT
Plasmacytoid bladder cancer is an aggressive histologic variant with a high risk of disease-specific mortality. Using whole-exome and targeted sequencing, we find that truncating somatic alterations in the CDH1 gene occur in 84% of plasmacytoid carcinomas and are specific to this histologic variant. Consistent with the aggressive clinical behavior of plasmacytoid carcinomas, which frequently recur locally, CRISPR/Cas9-mediated knockout of CDH1 in bladder cancer cells enhanced cell migration.
Related Questions
Is there data to support proceeding directly to cystectomy?
New answer by Medical Oncologist at AdventHealth Cancer Institute (August 28, 2020)
Plasmacytoid variant carcinoma is a rare aggressive variant that tends to be chemosensitive but recurs frequently and is characterized by CDH1 loss of function genomic alterat...
Any role for surgical extirpation vs systemic treatment?
New answer by Medical Oncologist at University of Michigan Medical School (September 2, 2021)
I think in this case neoadjuvant chemo followed by surgery, if feasible, should be considered. I would consider staging by PET to evaluate for other areas of disease. My one c...